Another issue entails provision of funding and resources for genetic research in addictions. Scientific funding agencies vary across countries, and drug addiction is often not a high research priority given the general belief that drug use can be controlled by the law (even though prohibition has not proven successful in the past), and many in the general public still tend to view it as an issue of willpower. Thus, there needs to be better education of the general public, health care providers, and policy makers on how to interpret genetic information. The general public tends to view genes as deterministic, and it is important to improve the ability to convey risk, as opposed to absolutes, when disseminating information on diseases such as drug addiction where many other factors also contribute. Individuals also need to be protected against companies that attempt to profit from unsound or presently un-validated genetic tests. The commercialization of genetic testing is well underway with companies offering sequencing services alongside a list of diseases to which one is susceptible for a price. There are also companies that
